ArticleBMC microbiology2026
Fourteen-year genomic surveillance of pediatric invasive Streptococcus pneumoniae: genomic and pan-genomic characterization.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundInvasive pneumococcal disease (IPD) poses a severe threat to children, with molecular epidemiological shifts driven by vaccination and antimicrobial pressure. Long-term genomic surveillance of pediatric IPD isolates is critical for optimizing prevention strategies.
methodsA total of 119 invasive Streptococcus pneumoniae (S. pneumoniae) strains were collected from children (2011–2024) at a tertiary children’s hospital. Whole-genome sequencing (WGS) was used for serotyping, Global Pneumococcal Sequencing Cluster (GPSC)/ Sequence type (ST) typing, phylogenetic analysis, antimicrobial resistance (AMR) and virulence gene profiling, and pan-genome analysis.
resultsThe top predominant serotypes were 19 F (26.1%), 14 (15.1%), 19 A (11.8%), and 6 F (10.9%). GPSC1 (37.0%) and GPSC4 (12.6%) were the major lineages, with ST271 (24.4%), ST876 (11.8%), and ST320 (10.9%) as the leading STs. Phylogenetic analysis clustered strains into two clades, with serotypes/GPSCs/STs showing distinct clustering. Pan-genome analysis revealed 3921 genes (36.2% core, 49.9% accessory, 13.9% unique) with an open structure. Clusters of Orthologous Groups (COG) annotations showed core genes enriched in metabolism (39.1%) and information storage/processing (31.3%), while accessory/unique genes focused on information storage/processing. Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations indicated metabolism as the dominant pathway (63.5%–70.5%) across gene categories, with unique genes enriched in human disease-related pathways (11.6%).
conclusionsThis 14-year genomic study reveals the dominant lineages and genetic characteristics of pediatric IPD strains. Pan-genome COG/KEGG annotations clarify functional genetic diversity, providing region-specific molecular epidemiological evidence for optimizing vaccine selection and clinical precision management of pediatric IPD in Zhejiang Province.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.